BlueWillow Biologics
Phil Wilmington is vice chairman at Workday, and focuses on building and expanding relationships with global customers, prospective customers, and strategic business partners, in addition to helping mentor the next generation of Workday sales leaders. Previously, from 2015 to 2018, Phil served as co-president.
Phil has more than 30 years’ experience in the enterprise software industry, most of which has been in executive management and leading customer-focused field operations. Prior to joining Workday, Phil served as president and chief operating officer at Tidemark Systems. Before Tidemark, he was president and CEO at OutlookSoft. Phil also previously served as co-president at PeopleSoft and held senior leadership positions at TriNet and Tesseract.
Phil holds a bachelor’s degree in marketing and business administration from Bradley University, and is a former member of the University’s board of trustees.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
BlueWillow Biologics
BlueWillow Biologics® is a clinical-stage, privately-held biopharmaceutical company focused on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. The platform employs novel oil-in-water nano-droplets for products administered to the skin and nose. The company was founded as a spin-off from the University of Michigan, and was initially focused on developing nano-scale dermatology applications. Based on promising research generated under several Gates Foundation, NIH and DOD contracts, BlueWillow’s technology has been advanced significantly in recent years yielding several therapies in development.